Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Polymer | 1,098.8 | 857.6 | 1,053.0 | 1,221.6 | 1,199.7 | 1,024.7 | | |
| Chemical | 871.3 | 705.6 | 751.5 | 790.1 | 760.7 | 719.4 | | |
| Total revenues [+] | 1,970.1 | 1,563.2 | 1,804.4 | 2,011.7 | 1,960.4 | 1,744.1 | 1,034.6 | 1,230.4 |
| Products | | | | | | 1,744.1 | 1,034.6 | 1,230.4 |
| Revenue growth [+] | 26.0% | -13.4% | -10.3% | 2.6% | 12.4% | 68.6% | -15.9% | -4.8% |
| Polymer | 28.1% | -18.6% | -13.8% | 1.8% | 17.1% | | | |
| Chemical | 23.5% | -6.1% | -4.9% | 3.9% | 5.7% | | | |
| Cost of goods sold | 1,381.4 | 1,165.3 | 1,390.0 | 1,431.1 | 1,415.7 | 1,262.5 | 806.0 | 993.4 |
| Gross profit | 588.8 | 397.9 | 414.4 | 580.6 | 544.7 | 481.6 | 228.7 | 237.1 |
| Gross margin | 29.9% | 25.5% | 23.0% | 28.9% | 27.8% | 27.6% | 22.1% | 19.3% |
| Selling, general and administrative | 164.2 | 161.9 | 149.8 | 153.9 | 161.3 | 177.4 | 117.3 | 104.2 |
| Research and development | 40.4 | 40.7 | 41.1 | 41.3 | 40.3 | 39.1 | 31.0 | 31.4 |
| Equity in earnings | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 | -0.4 | 0.4 | 0.4 |
| Other operating expenses | -1.2 | -175.2 | | | | | | |
| EBITDA [+] | 384.9 | 369.9 | 223.1 | 384.9 | 342.7 | 264.7 | 80.7 | 101.9 |
| EBITDA growth | 4.0% | 65.8% | -42.1% | 12.3% | 29.5% | 227.9% | -20.8% | 14.8% |
| EBITDA margin | 19.5% | 23.7% | 12.4% | 19.1% | 17.5% | 15.2% | 7.8% | 8.3% |
| Depreciation | 85.4 | 83.0 | 90.2 | 92.1 | 84.8 | 80.8 | 50.9 | 55.0 |
| EBITA | 299.5 | 286.9 | 132.9 | 292.8 | 257.9 | 183.9 | 29.8 | 46.9 |
| EBITA margin | 15.2% | 18.4% | 7.4% | 14.6% | 13.2% | 10.5% | 2.9% | 3.8% |
| Amortization of intangibles | 41.1 | 43.0 | 46.0 | 49.3 | 52.4 | 44.9 | 11.2 | 11.2 |
| EBIT [+] | 258.4 | 243.9 | 86.9 | 243.5 | 205.5 | 139.0 | 18.6 | 35.7 |
| EBIT growth | 5.9% | 180.7% | -64.3% | 18.5% | 47.8% | 646.0% | -47.7% | 39.2% |
| EBIT margin | 13.1% | 15.6% | 4.8% | 12.1% | 10.5% | 8.0% | 1.8% | 2.9% |
| Non-recurring items [+] | 2.0 | 575.9 | -32.1 | -6.7 | 0.5 | 0.7 | | 4.7 |
| Asset impairment | | 400.0 | | | | | | 4.7 |
| Loss (gain) on sale of assets | 0.9 | 0.8 | 0.8 | 2.2 | 0.5 | 0.7 | | |
| Unusual expense | | | -32.9 | -8.9 | | | | |
| Interest expense | 41.8 | 57.9 | 75.8 | 93.8 | 132.5 | 139.0 | 24.2 | 24.6 |
| Interest expense | 41.8 | 57.9 | 75.8 | 93.8 | 132.5 | 139.0 | 24.2 | 24.6 |
| Other income (expense), net [+] | 0.6 | 136.3 | 0.8 | -82.4 | -37.8 | 13.3 | | |
| Gain (loss) on sale of assets | | | | | | 28.4 | | |
| Gain (loss) on debt retirement | | -40.8 | -3.5 | -79.9 | -35.4 | -13.4 | | |
| Pre-tax income | 215.1 | -253.7 | 44.0 | 74.1 | 34.8 | 12.7 | -5.6 | 6.3 |
| Income taxes | 39.5 | -32.0 | -11.8 | 3.6 | -57.9 | -92.0 | 6.9 | 5.1 |
| Tax rate | 18.4% | 12.6% | | 4.8% | | | | 80.9% |
| Minority interest | 5.4 | 3.9 | 4.5 | 3.5 | -4.9 | -2.7 | -2.0 | -1.2 |
| Net income | 170.2 | -225.6 | 51.3 | 67.0 | 97.5 | 107.3 | -10.5 | 2.4 |
| Net margin | 8.6% | -14.4% | 2.8% | 3.3% | 5.0% | 6.2% | -1.0% | 0.2% |
| |
| Basic EPS [+] | $5.30 | ($7.11) | $1.62 | $2.13 | $3.18 | $3.56 | ($0.34) | $0.08 |
| Growth | -174.6% | -537.4% | -23.8% | -33.0% | -10.5% | -1131.9% | -558.1% | -490.6% |
| Diluted EPS [+] | $5.21 | ($7.11) | $1.61 | $2.11 | $3.13 | $3.50 | ($0.34) | $0.07 |
| Growth | -173.4% | -541.6% | -23.7% | -32.7% | -10.6% | -1117.0% | -562.7% | -486.8% |
| |
| Shares outstanding (basic) [+] | 32.1 | 31.7 | 31.6 | 31.4 | 30.7 | 30.2 | 30.6 | 32.2 |
| Growth | 1.1% | 0.5% | 0.5% | 2.5% | 1.6% | -1.3% | -4.9% | 0.2% |
| Shares outstanding (diluted) [+] | 32.6 | 31.7 | 31.9 | 31.8 | 31.1 | 30.6 | 30.6 | 32.5 |
| Growth | 2.8% | -0.4% | 0.3% | 2.1% | 1.7% | 0.2% | -5.9% | 1.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|